| scholarly article | Q13442814 |
| P50 | author | Thierry Defrance | Q62669243 |
| Valérie Dubois | Q63920017 | ||
| Thierry Berney | Q64497420 | ||
| Olivier Thaunat | Q64918274 | ||
| Chien-Chia Chen | Q83261338 | ||
| Sandrine Bacot | Q114563802 | ||
| Alexis Broisat | Q49079451 | ||
| Francesco Andreata | Q55381344 | ||
| Mitra Ahmadi | Q57469521 | ||
| Meng-Kun Tsai | Q59189442 | ||
| Antonino Nicoletti | Q44231209 | ||
| P2093 | author name string | Jean Villard | |
| Marie-Nathalie Kolopp-Sarda | |||
| Patrick Bruneval | |||
| Jean-Paul Duong Van Huyen | |||
| Emmanuel Morelon | |||
| Alexandre Loupy | |||
| Laurence Kessler | |||
| Catherine Ghezzi | |||
| Sandrine Demuylder-Mischler | |||
| Alice Koenig | |||
| Maud Racapé | |||
| Virginie Mathias | |||
| Eric Pouliquen | |||
| Stéphanie Ducreux | |||
| Carole Saison-Delaplace | |||
| Marina Marcaud | |||
| P2860 | cites work | Type 1 diabetes | Q27000491 |
| HLA antibody detection with solid phase assays: great expectations or expectations too great? | Q27015921 | ||
| Transplantation of isolated pancreatic islets into the portal vein of diabetic rats | Q28237741 | ||
| Predominant autoantibody production by early human B cell precursors | Q29619656 | ||
| Improvement in outcomes of clinical islet transplantation: 1999-2010. | Q30418470 | ||
| Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry | Q30956324 | ||
| Immune responses elicited in tertiary lymphoid tissues display distinctive features | Q33627619 | ||
| Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes | Q75197031 | ||
| Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetes patients | Q80346010 | ||
| Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence | Q82496190 | ||
| A NOVel ELISPOT assay to quantify HLA-specific B cells in HLA-immunized individuals | Q83572210 | ||
| Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects | Q84547719 | ||
| Simple linear regression. | Q50724614 | ||
| Anti-Donor HLA Antibody Response After Pancreatic Islet Grafting: Characteristics, Risk Factors, and Impact on Graft Function. | Q51682057 | ||
| De novo donor-specific HLA antibodies: biomarkers of pancreas transplant failure. | Q53851101 | ||
| B cell survival in intragraft tertiary lymphoid organs after rituximab therapy. | Q54528998 | ||
| Important parameters for evaluation of antibody avidity by immunosorbent assay | Q58861237 | ||
| Chronic Rejection Triggers the Development of an Aggressive Intragraft Immune Response through Recapitulation of Lymphoid Organogenesis | Q59387561 | ||
| Effects of Pancreatic Transplantation on Diabetic Neuropathy | Q60681694 | ||
| Islet Autotransplant Outcomes After Total Pancreatectomy: A Contrast to Islet Allograft Outcomes | Q61651168 | ||
| Donor islet endothelial cells in pancreatic islet revascularization | Q34004538 | ||
| Lymphoid neogenesis in chronic rejection: evidence for a local humoral alloimmune response | Q34078561 | ||
| Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene | Q34456230 | ||
| Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. | Q35027253 | ||
| RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock. | Q35377560 | ||
| Recent advances in renal transplantation: antibody-mediated rejection takes center stage | Q35659332 | ||
| Markedly decreased blood perfusion of pancreatic islets transplanted intraportally into the liver: disruption of islet integrity necessary for islet revascularization | Q35766950 | ||
| Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients. | Q35790585 | ||
| Skin effector memory T cells do not recirculate and provide immune protection in alemtuzumab-treated CTCL patients. | Q36026719 | ||
| Antibody-mediated organ-allograft rejection | Q36263023 | ||
| Chronic inflammation caused by lymphotoxin is lymphoid neogenesis | Q36366337 | ||
| IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury | Q36417907 | ||
| Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes | Q36796037 | ||
| A novel pathway of chronic allograft rejection mediated by NK cells and alloantibody | Q36887068 | ||
| GDF15 triggers homeostatic proliferation of acid-secreting collecting duct cells | Q36906059 | ||
| Access of protective antiviral antibody to neuronal tissues requires CD4 T-cell help | Q36943725 | ||
| Optimal implantation site for pancreatic islet transplantation | Q37320025 | ||
| Anti-inflammatory strategies to enhance islet engraftment and survival | Q38126385 | ||
| Immunogenicity of Anti-HLA Antibodies in Pancreas and Islet Transplantation | Q39119058 | ||
| Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts | Q39305636 | ||
| A stepwise breakdown of B-cell tolerance occurs within renal allografts during chronic rejection | Q39470034 | ||
| HLA monomers as a tool to monitor indirect allorecognition | Q39902815 | ||
| Insulin independence after islet transplantation into type I diabetic patient | Q41195322 | ||
| De Novo Donor-Specific HLA Antibodies Are Associated With Rapid Loss of Graft Function Following Islet Transplantation in Type 1 Diabetes | Q41530090 | ||
| Diagnostic challenges in chronic antibody-mediated rejection | Q41832267 | ||
| Histogenesis and ultrastructure of pancreatic islet graft microvasculature. Evidence for graft revascularization by endothelial cells of host origin. | Q42049829 | ||
| Posttransplant donor-specific anti-HLA antibodies negatively impact pancreas transplantation outcome. | Q43658900 | ||
| Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice | Q44051149 | ||
| Angiogenic capacity of endothelial cells in islets of Langerhans | Q44387391 | ||
| A technique of cervical heterotopic heart transplantation in mice | Q45077658 | ||
| Beta-score: an assessment of beta-cell function after islet transplantation | Q45242345 | ||
| Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
| Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
| HLA class I antibody-mediated endothelial cell proliferation via the mTOR pathway | Q46142365 | ||
| Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets | Q47690560 | ||
| Reversal of lesions of diabetic nephropathy after pancreas transplantation | Q47879758 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 219-232 | |
| P577 | publication date | 2017-11-20 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Endothelial chimerism and vascular sequestration protect pancreatic islet grafts from antibody-mediated rejection | |
| P478 | volume | 128 |
| Q90166947 | Advances in β-cell replacement therapy for the treatment of type 1 diabetes |
| Q64069939 | Highly Variable Sialylation Status of Donor-Specific Antibodies Does Not Impact Humoral Rejection Outcomes |
| Q91451420 | Missing self triggers NK cell-mediated chronic vascular rejection of solid organ transplants |
Search more.